Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705705 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks
A Phase 2 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 852
- Enrollment target
NCT00705705: Completed Phase 2 study, sponsored by Medical College of Wisconsin.
NCT00705705 is a Phase 2 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 852 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (541% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00705705, a Phase 2 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 852 participants
- Enrollment target
Study Summary
This study will determine whether an HIV prevention program that targets the inner workings of social networks at high risk for HIV and other sexually transmitted diseases is effective in reducing frequency of high-risk sexual behaviors among network members.
Interventions
- BEHAVIORAL Network leader training
- BEHAVIORAL Standard HIV risk-reduction counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 852 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
What the finished NCT00705705 record still lists
NCT00705705 is an interventional study that assigns participants to a tested intervention. The registered 852 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (541% higher).
The record links to 0 conditions, and to 2 interventions - of which Network leader training is the first listed.
NCT00705705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00705705 about?
NCT00705705 is a clinical study titled "Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks". This study will determine whether an HIV prevention program that targets the inner workings of social networks at high risk for HIV and other sexually transmitted diseases is effective in reducing frequency of high-risk sexual behaviors among network members.
What is the current status of trial NCT00705705?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 852 participants. The study started on 2004-07. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00705705?
The interventions under investigation include: Network leader training (BEHAVIORAL), Standard HIV risk-reduction counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00705705?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00705705's enrollment target sits among peer trials
852 35th of 2000 higher than 1,966 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06237452 · 852 participants · Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
- NCT06422143 · 851 participants · Phase 3
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- NCT07005102 · 854 participants · Phase 2
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- NCT07290491 · 854 participants · Phase 3
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia